Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Darlinghurst NSW, Australia Clinical Trials

A listing of Darlinghurst NSW, Australia clinical trials actively recruiting patients volunteers.

RESULTS

Found (5) clinical trials

A Study of LY3434172 a PD-1 and PD-L1 Bispecific Antibody in Advanced Cancer

The main purpose of this study is to evaluate the safety and tolerability of the study drug LY3434172, a PD-1/PD-L1 bispecific antibody, in participants with advanced solid tumors.

Phase

0.52 miles

Learn More »

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

This research study will examine the safety and effectiveness of ONS-5010 in participants with AMD. The goal is to prevent vision loss by evaluating the effectiveness of ONS-5010 as compared with ranibizumab.

Phase

0.9 miles

Learn More »

Pharmacokinetics Safety and Tolerability Study of AVT02 to EU-approved and US-licensed Humira (Adalimumab)

AVT02 is being developed as a biosimilar to Humira. EU-Humira and US-Humira have therefore been selected as the active control groups in this study. This study is designed as a multi-center, randomised, double-blind, 3-arm parallel study of AVT02 compared to EU-Humira and US-Humira in healthy adult subjects. The study is ...

Phase

2.6 miles

Learn More »

Safety Tolerability Pharmacokinetics and Efficacy of AMG 160 in Subjects With mCRPC

This is a phase I, first-in-human study to evaluate the safety and tolerability of AMG 160, a half-life extended (HLE) bispecific T-cell engager (BiTE) antibody, in subjects with metastatic castration-resistant prostate cancer.

Phase

2.64 miles

Learn More »

A Biomarker-directed Study of XPro1595 in Patients With Mild to Moderate Alzheimer's

The study is designed as a multicentre, phase 1b open-label study. The objectives of this study are to determine the safety, tolerability, and efficacy of XPro1595 in patients with mild to moderate Alzheimer's disease and elevated blood levels of the inflammatory biomarker high sensitivity c-reactive protein (hs-CRP). XPro1595 is a ...

Phase

7.65 miles

Learn More »